.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Microwave ablation thyroid nodules treatment has surfaced as a powerful alternative to traditional surgery for benign growths. Researchers recently evaluated 123 patients with solid nodules larger than 10 mL. Consequently, they found that microwave ablation (MWA) offers significant clinical benefits with minimal risks.
The volume reduction rate (VRR) reached over 80% during the mean follow-up of 28 months. Specifically, nearly 92% of patients achieved a 50% reduction within the first year. Moreover, symptom and cosmetic scores improved significantly after the procedure. Therefore, this technique provides a reliable solution for patients who wish to avoid invasive operations.
The study highlighted that MWA is particularly effective for large solid nodules. Additionally, the procedure proved safe even for high-risk surgical patients. Furthermore, researchers reported no major complications like permanent nerve injury. Importantly, most patients experienced significant relief from compression symptoms. Consequently, clinicians can recommend this minimally invasive approach for various patient subgroups.
Studies show a mean Volume Reduction Rate (VRR) of 80.73% over 28 months, with over 90% of patients achieving at least 50% reduction within the first year.
Yes, the retrospective study demonstrated that MWA is safe and effective even in high-risk surgical subgroups, with no major complications reported.
Patient-reported symptom scores drop significantly, and cosmetic scores improve markedly, making it an excellent organ-preserving alternative to surgery.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Gong L et al. Effectiveness and outcomes of microwave ablation for solid benign thyroid nodules (>10mL): a retrospective study. Int J Hyperthermia. 2026 Dec undefined. doi: 10.1080/02656736.2026.2659372. PMID: 42003534.
Karacay E et al. Comparison of two ablation methods in benign thyroid nodules: Radiofrequency ablation and non-cooled microwave ablation. J Clin Imaging Sci. 2026;16:3.
Karaca C et al. Predictors of Volume Reduction Rate Following Microwave Ablation for Benign Thyroid Nodules: A Systematic Review and Meta-Analysis. Ultrasound Med Biol. 2026.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A retrospective study shows that microwave ablation for large benign thyroid nodules achieves 80% volume reduction and improves clinical symptoms safely....
6 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
